Biotech

All Articles

Analysts dig into Avidity's DMD gain, showing subtleties in records

.Avidity Biosciences amazed investors along with period 1/2 records in Duchenne muscular dystrophy (...

Actinogen's cortisol blocker falls short period 2 clinical depression research study

.Actinogen Medical's cortisol blocker has actually overlooked the main endpoint of a stage 2 study i...

Bivictrix chooses going private only way to take ADC in to medical clinic

.Antibody-drug conjugates (ADCs) have gone to the center of numerous a billion-dollar biobuck licens...

TPG leadings up funds to $580M for investments around life sciences

.Property manager TPG, which has actually assisted biotechs such as Sionna Therapeutics as well as S...

Merck stops period 3 TIGIT trial in lung cancer cells for futility

.Merck &amp Co.'s TIGIT program has actually experienced one more obstacle. Months after shuttering ...

After a difficult year, Exscientia folds right into Recursion

.After a year determined by pipeline hairstyles, the variation of its chief executive officer as wel...

Cullinan, after $25M offer, return bispecific to Harbour

.Cullinan Rehab was thrilled sufficient with Port BioMed's bispecific invulnerable activator that it...

A deeper examine Strong Biotech's Brutal 15

.Within this full week's incident of "The Best Pipe," our company are actually diving into Fierce Bi...

Lilly experiences period 2 failing of tau-targeting med

.The confetti is actually still flying coming from Eli Lilly's celebration commemorating the approva...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of notable management hirings, firings and re...